3
Participants
Start Date
July 17, 2024
Primary Completion Date
March 6, 2025
Study Completion Date
May 1, 2025
Abiprubart
humanized monoclonal antibody
Placebo
sterile preservative-free solution
Accellacare (Salisbury), Salisbury
Carolina Arthritis Associates, Wilmington
International Medical Research, Daytona Beach
Omega Research Debary, LLC, DeBary
Clinic of Robert Hozman, MD/Clinical Investigation Specialists, Inc., Skokie
Greater Chicago Specialty Physicians/ Clinical Investigation Specialists, Schaumburg
Springfield Clinic Rheumatology, Springfield
Accurate Clinical Research, Inc, Lake Charles
Arthritis and Rheumatology Research Institute, PLLC, Allen
Trinity Universal Research Associates, Inc., Plano
Arthritis & Osteoporosis Clinic, Waco
Sun Research Institute, San Antonio
Arthritis Care of Texas, Corpus Christi
Medvin Clinical Research, Whittier
BioSolutions Clinical Research Center, Poway
Medvin Clinical Research, Menifee
Lead Sponsor
Collaborators (1)
Kiniksa Pharmaceuticals, GmbH
INDUSTRY
Kiniksa Pharmaceuticals International, plc
INDUSTRY